With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...

Merck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication ...

<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T6GGB6V" height="0" width="0" style="display:none;visibility:hidden"></iframe> ...

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

Merck of Whitehouse Station, New Jersey, has halted development of its lead biogeneric product, MK-2578, a PEGylated erythropoietin-stimulating agent for treating anemia. The decision, announced ...

Drugmakers have greeted 2025, implementing price hikes for 583 products within the first two days of the new year, according to 46brooklyn Research. Read more here.